Albumin

Albumin, abbreviated ALB, is classified as a liver biomarker. It is reported as a concentration, making it a laboratory value used within the broader group of liver-related biomarkers.

Albumin is measured from a serum sample. Fasting is not required for this test, so the collection does not need to be arranged after an overnight fast.

When arranging testing, check that the result is reported in g/L so it can be compared with the reference and optimal ranges shown alongside the result. Albumin is treated as a higher-is-better biomarker in this reference, but a result should be interpreted in context rather than on its own.

Related markers that may be considered alongside Albumin include Total Protein and Globulins. For questions about what a result means in relation to a medical condition, interpretation with a clinician can help place it in the appropriate context.

Albumin results should be read against the reference range printed on the same laboratory report, using the report’s units. A value inside that interval is within the laboratory’s reference range. The optimal range is narrower and represents a tighter target within the broader reference interval; being outside the optimal range does not, by itself, establish a medical problem.

Laboratories may use different reference ranges and units, so a number is meaningful only when interpreted alongside the range shown on that report. This result is measured in serum, and fasting is not required for the test.

A single albumin value is not a diagnosis. Results outside the report’s reference range should be discussed with a clinician, who can interpret them in the context of the person’s health and other findings.

Albumin has been measured directly in trials of several interventions. Increases were reported with Omega-3, L-Carnitine, Resveratrol, Sodium Bicarbonate, Zinc, Astragalus, Whey Protein, BCAA, Hatha Yoga, Coenzyme Q10, and MCT Oil. Albumin was unchanged with L-Leucine, Quercetin, Curcumin, and Milk Thistle (Silymarin). These results describe movement in the measured marker itself; an increase represents movement toward higher albumin, while an unchanged result does not support a measurable shift under the studied conditions.

The evidence is not equally consistent across the interventions. Some increasing results included neutral findings in other trials, whereas the unchanged results were consistently neutral within the available studies. The time between an intervention and albumin reassessment ranged from 1.0 to 260.7 weeks, so timing is an important part of interpreting a result; Hatha Yoga was associated with an increase after four months, and MCT Oil was assessed after 11 days. These findings are educational and do not indicate that any option is appropriate for a particular medical condition; interpretation is best discussed with a clinician.